A detailed history of Cravens & CO Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cravens & CO Advisors, LLC holds 9,680 shares of ABT stock, worth $1.14 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
9,680
Previous 7,253 33.46%
Holding current value
$1.14 Million
Previous $824 Million 22.01%
% of portfolio
0.75%
Previous 0.68%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$100.73 - $112.44 $244,471 - $272,891
2,427 Added 33.46%
9,680 $1.01 Billion
Q1 2024

Apr 02, 2024

BUY
$109.52 - $120.96 $37,674 - $41,610
344 Added 4.98%
7,253 $824 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $26,696 - $32,678
-296 Reduced 4.11%
6,909 $760 Million
Q3 2023

Nov 15, 2023

BUY
$95.53 - $114.62 $11,272 - $13,525
118 Added 1.67%
7,205 $698 Million
Q2 2023

Jul 27, 2023

SELL
$100.78 - $112.29 $2,519 - $2,807
-25 Reduced 0.35%
7,087 $773 Million
Q1 2023

May 26, 2023

BUY
$96.86 - $114.01 $16,466 - $19,381
170 Added 2.45%
7,112 $720 Million
Q4 2022

Feb 24, 2023

BUY
$95.06 - $111.52 $659,906 - $774,171
6,942 New
6,942 $762 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cravens & CO Advisors, LLC Portfolio

Follow Cravens & CO Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cravens & CO Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cravens & CO Advisors, LLC with notifications on news.